Case Studies in Myeloma: Nursing Implications of Evolving Treatment Paradigms

A symposium held at the Oncology Nursing Society 40th Annual Congress
Date and Time: Thursday, April 23, 2015 from 12 pm – 1:30 pm

Hyatt Regency Orlando
Meeting Room – Plaza D-H
9801 International Drive
Orlando, FL 32819
Program & Lunch

This activity is supported by an educational grant from Bristol-Myers Squibb, Celgene Corporation, Onyx Pharmaceuticals and Takeda Oncology.
This activity is jointly provided by Medical Education Resources, the International Myeloma Foundation, and CMEFirst, LLC.

Beth Faiman, PhD, MSN, APRN-BC, AOCN®
Adult Nurse Practitioner
Multiple Myeloma Program
Cleveland Clinic Foundation
Taussig Cancer Institute Cleveland, OH

Joseph D. Tariman, PhD, ANP-BC
Assistant Professor
School of Nursing/College of Science and Health
De Paul University, Chicago, IL

Sandra Kurtin, RN, MS, AOCN®, ANP-C
Hematology/Oncology Nurse Practitioner
The University of Arizona Cancer Center
Clinical Assistant Professor of Medicine
Adjunct Clinical Professor of Nursing
The University of Arizona, Tucson, AZ

Teresa S. Miceli, RN, BSN, OCN®
BMT RN Care Coordinator
Assistant Professor of Nursing
Adult Blood and Marrow Transplant Program
Mayo Clinic, Rochester, MN

Case-based Presentations
Case #1 Key concepts: MGUS, New Definitions of Smoldering Multiple Myeloma and Active Multiple Myeloma, Clinical Trial Participation, Minimal Residual Disease, Treatment for Newly Diagnosed Myeloma

Case #2 Key concepts: Clonal Evolution, Continuous Therapy Benefits, Relapsed/Refractory Myeloma, Emerging Therapies, Clinical Trials, Survivorship Care

Educational Need
This symposium will discuss the crucial role nurses play in managing myeloma patients including preventing complications, ensuring adherence, advocating for patients, involving caregivers, and managing treatment-related adverse events. Tools and information, including the Nurse Leadership Board’s publications, will be integrated and demonstrated during this event, empowering nurses to enhance current patient care efforts.

Target Audience
This activity has been designed to meet the educational needs of oncology nurses, in either community or academic settings, that are involved in the care of patients with multiple myeloma.

Learning Objectives
To educate and provide practical recommendations to nurses for optimal management and care of multiple myeloma patients.

  • Describe changes in myeloma treatment paradigms and related nursing implications
    – Earlier stages of myeloma
    – Minimal residual disease
  • Discuss new and upcoming therapies in multiple myeloma, their appropriate use, and related patient management
  • Identify components of a survivorship care plan
  • Employ practical tools and recommendations for long-term care and management of multiple myeloma patients

Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

Nursing Credit
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 1.5 contact hours of continuing nursing education.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.5 contact hours.

ONS Disclaimer
Meeting space has been assigned to provide a Symposia supported by The International Myeloma Foundation via an educational grant during the Oncology Nursing Society’s (ONS) 40th Annual Congress, April 23-26, 2015 in Orlando, FL. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement nor does the Oncology Nursing Society assume any responsibility for the educational content of the symposium.

Fee Information
There is no fee for this educational activity.

Registration Information
You will receive an email confirmation following your registration. Please note that space is limited, so we suggest that you register as soon as possible!
If you need any assistance in registering for the event, please contact CMEFirst at 412-401-0726 or